1 / 39

Görsev G. Yener , M.D. Neurology , Dokuz Eylül University Izmir, Turkey gorsev.yener@deu.tr

Frontotemporal lobar degeneration: demographic and clinical characteristics in a Turkish dementia population. Görsev G. Yener , M.D. Neurology , Dokuz Eylül University Izmir, Turkey gorsev.yener@deu.edu.tr. FTLD Prevalence. Not clear ( 4- 16%) Common cause pre-senile dementia

colorado-whitley
Télécharger la présentation

Görsev G. Yener , M.D. Neurology , Dokuz Eylül University Izmir, Turkey gorsev.yener@deu.tr

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Frontotemporal lobar degeneration: demographic and clinical characteristics in a Turkish dementia population Görsev G. Yener, M.D. Neurology, Dokuz Eylül University Izmir, Turkey gorsev.yener@deu.edu.tr

  2. FTLD Prevalence Not clear (4-16%) Common cause pre-senile dementia 1:1 with AD 45-64 years (Ratnavalli Neurology 2002) more common than AD below 60 years (Knopman Neurology 2004)

  3. FTLDin Izmir, Turkey Demographic data Genetics/Pathological Syndrome Neary Criteria – FTD, PA, SD MND association

  4. 1994-2004 Izmir DEU Dementia Clinic N=1169 Demented= 66 % AD (possible / probable) 67 % Vascular dementia 15 % Fronto-temporal dementia 4 % Lewy body dementia 9 %

  5. FTLD Clinical Heterogeneity • Genetic & sporadic cases • Histology varies • Motor overlap with PSP, CBD, ALS

  6. Neary Criteria • Frontotemporal Lobar Degeneration • Frontotemporal Dementia • Progressive Non-Fluent Aphasia • Semantic Dementia Neary et al. 1998, Neurology

  7. Dokuz Eylül University Dementia and Movement Disorders Clinics • 1994-2001 • 35 FTLD, 25 PSP, 5 CBD cases • Demographic and clinical features • Webster • MMSE (subitems)

  8. FTLD: Gender Turkish (N=35) (% male) US (N=353) (% male) ** ** Age (Years) Johnson et al. Arch Neurol. 2005;62:925-930. Yener et al 2002

  9. FTLD: Age at Onset US (N=353) Turkish (N=35) ** ? Age (Years) Johnson et al. Arch Neurol. 2005;62:925-930. Yener et al 2002

  10. Presenile onset (%) -Turkish **

  11. Family history • 40-60 % • In Netherland series 38% • (15 million screened) • Family Hx (+) , RR=3.5

  12. Family Hx (%)-Turkish population **

  13. FTLD Pathological SyndromeCore Features • Frontotemporal predominance • Gliosis, spongiosus, neuronal loss

  14. Variable Histological Features • Neuronal inclusions with ubiquitin • (Clinical: MND, ALS, Paget, Inclusion body myositis) • Neuronal inclusions with tau • (Clinical: FTDP-17, PSP, CBD) • Other inclusions • (Neuronal intermediate filament inclusion dementia) • No inclusions (DLDH) • (Clinical: FTLD)

  15. Pick Bodies Cerebral cortex (Described by Alzheimer in 1911)

  16. a b c d A. B. Distance travelled by the tau species (m) Time (minutes) 0N4R-EGFP 0N4R-untagged Courtesy of Tim Hutton, Cambridge, UK

  17. Tau mutations

  18. Neuronal ubiquitinated intranuclear inclusions in familial and non-familial FTD-MND associated with ALS Bigio, et al, 2004, J Neuropath Exp Neurol, 63(8): 801 811

  19. FTD with ubiquitinated neuronal inclusions and visuospatial impairment Meiner et al Neurology 2005;65:478–480

  20. Ubiquitin and Tau • Ubiquitin is a marker for a given protein to be sent to a proteasome for degradation • Ubiquitin proteins are also needed for the degradation of tau

  21. FTD Neuropathology Subtypes • FTD-Ub related to MND subtype • CBD, PSP major tau subtype • DLDH less common with new staining techniques

  22. Clinical Features • Subtypes • MND • Parkinsonism • MMSE

  23. FTLD subtypes in the US and Turkey 3 sites (N=353) Johnson et al. Arch Neurol. 2005;62:925-930. 1 site (N=35) Yener et al 2002

  24. MND and FTDare associated • FTD is associated with MND (15%) • Most ALS patients develop FTD • FTLD-ALS chr 9 and 17 • Hypometabolism in frontal lobes in ALS

  25. Brain atrophy in ALS and ALS/FTLD Chang et al, Neurology 2005;65:75–80

  26. Turkish FTLD and MND

  27. Webster scores-Turkish FTLD subtypes Clinical Features-Parkinsonism **

  28. Clinical Features • Parkinsonism appears earlier in FTLD • MND - more often parkinsonism • No tau mutation was found in FTD-MND group.

  29. MMSE Scores in Turkish FTLD

  30. MMSE Figure copying (%)

  31. Clinical patterns PSP~CBD • Both higher Webster and MMSE scores • MMSE figure copy is discriminative

  32. Clinical patterns • Webster scores • FTD-MND > FTLD • MMSE scores • FTD-MND = FTLD • preserved figure copying • FTD-MND > FTLD

  33. Clinical patterns FTLD subtypes • total MMSE PNFA < SD < FTD • figure copy SD < PNFA < FTD

  34. Conclusions • FTLD common in presenile ages • Turkish FTLD subtypes have similar profile to the US • FTD> PNFA > SD

  35. Conclusions • Higher family Hx than other dementias (54%) • FTLD-MND association (22%) • FTD-MND has higher parkinsonism scores

More Related